首页> 外国专利> SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

机译:组氨酸去乙酰化酶1和2的选择性抑制作为心脏肥大的治疗方法

摘要

The present invention provides for methods of treating and preventing cardiac hypertrophy. Class I HDACs, which are known to participate in regulation of chromatin structure and gene expression, have generally been considered as prohypertrophic in their action. However, the present invention demonstrates that inhibition of certain Class I HDACs should be avoided in the treatment of cardiac hypertrophy, thereby pointing toward selective, and not global, inhibition of Class I HDACs. In particular, the present invention provides for selective inhibition of HDACs 1 and/or 2, and the avoidance of inhibition of HDAC3.
机译:本发明提供了治疗和预防心脏肥大的方法。已知参与染色质结构和基因表达的调节的I类HDAC通常被认为在其作用中是肥大的。然而,本发明证明在心脏肥大的治疗中应避免对某些I类HDAC的抑制,从而指向对I类HDAC的选择性而非整体抑制。特别地,本发明提供了对HDAC 1和/或2的选择性抑制,以及避免了对HDAC3的抑制。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号